Lu Hongbo is Director of ARROWHEAD PHARMACEUTICALS, INC.. Currently has a direct ownership of 33,680 shares of ARWR, which is worth approximately $647,666. The most recent transaction as insider was on Mar 20, 2024, when has been sold 1,000 shares (Common Stock) at a price of $27.5 per share, resulting in proceeds of $27,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 33.7K
0% 3M change
n/a 12M change
Total Value Held $647,666

Lu Hongbo Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 20 2024
BUY
Open market or private purchase
$27,500 $27.5 p/Share
1,000 Added 2.88%
33,680 Common Stock
Mar 19 2024
BUY
Open market or private purchase
$28,000 $28.0 p/Share
1,000 Added 2.97%
32,680 Common Stock
Mar 18 2024
BUY
Open market or private purchase
$27,490 $27.49 p/Share
1,000 Added 3.06%
31,680 Common Stock

Also insider at

TPTX
Turning Point Therapeutics, Inc.
TERN
Terns Pharmaceuticals, Inc. Healthcare
ZBIO
Zenas BioPharma, Inc.
 Lu Hongbo

Lu Hongbo

Director
San Diego, CA

Track Institutional and Insider Activities on ARWR

Follow ARROWHEAD PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARWR shares.

Notify only if

Insider Trading

Get notified when an Arrowhead Pharmaceuticals, Inc. insider buys or sells ARWR shares.

Notify only if

News

Receive news related to ARROWHEAD PHARMACEUTICALS, INC.

Track Activities on ARWR